Gene · 7364
Papers2,547
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,547
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development. | Acta Pharm Sin B | 2022 | 35755285 | PubTator, text mining | PubMed |
| Pharmacokinetics and Tissue Distribution of Enavogliflozin in Mice and Rats. | Pharmaceutics | 2022 | 35745783 | PubTator, text mining | PubMed |
| Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review. | Pharmaceutics | 2022 | 35745763 | PubTator, text mining | PubMed |
| Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug-drug interaction studies. | Clin Transl Sci | 2022 | 35722783 | PubTator, text mining | PubMed |
| Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer. | Mol Med | 2022 | 35715741 | PubTator, text mining | PubMed |
| Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide. | Ther Adv Neurol Disord | 2022 | 35706844 | PubTator, text mining | PubMed |
| Effects of UGT2B7 rs7662029 and rs7439366 polymorphisms on sublingual buprenorphine metabolism in heroin addicts: An improved PCR-RFLP assay for the detection of rs7662029 polymorphism. | Environ Toxicol Pharmacol | 2022 | 35697190 | PubTator, text mining | PubMed |
| Statement on safety of cannabidiol as a novel food: data gaps and uncertainties. | EFSA J | 2022 | 35686177 | PubTator, text mining | PubMed |
| The Comparison of the Efficiency of Emodin and Aloe-Emodin in Photodynamic Therapy. | Int J Mol Sci | 2022 | 35682955 | PubTator, text mining | PubMed |
| Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis. | Cancers (Basel) | 2022 | 35681563 | PubTator, text mining | PubMed |
| Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology. | Front Cardiovasc Med | 2022 | 35677689 | PubTator, text mining | PubMed |
| Hypercholesterolemia reduces the expression and function of hepatic drug metabolizing enzymes and transporters in rats. | Toxicol Lett | 2022 | 35654319 | PubTator, text mining | PubMed |
| SLC4A4, FRAS1, and SULT1A1 Genetic Variations Associated With Dabigatran Metabolism in a Healthy Chinese Population. | Front Genet | 2022 | 35646073 | PubTator, text mining | PubMed |
| Morphine-3-Glucuronide, Physiology and Behavior. | Front Mol Neurosci | 2022 | 35645730 | PubTator, text mining | PubMed |
| The inhibition of tamoxifen on UGT2B gene expression and enzyme activity in rat liver contribute to the estrogen homeostasis dysregulation. | BMC Pharmacol Toxicol | 2022 | 35642027 | PubTator, text mining | PubMed |
| Examining Physiologically Based Pharmacokinetic Model Assumptions for Cross-Tissue Similarity of Activity per Unit of Enzyme: The Case Example of Uridine 5'-Diphosphate Glucuronosyltransferase. | Drug Metab Dispos | 2022 | 35636771 | PubTator, text mining | PubMed |
| Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug-Drug-Gene Interaction Predictions. | Pharmaceutics | 2022 | 35631502 | PubTator, text mining | PubMed |
| Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Patients: A Comparison of the Early and Stable Posttransplant Stages. | Front Pharmacol | 2022 | 35614937 | PubTator, text mining | PubMed |
| Exosomes and their roles in the chemoresistance of pancreatic cancer. | Cancer Med | 2022 | 35587712 | PubTator, text mining | PubMed |
| Variability in the Beneficial Effects of Phenolic Compounds: A Review. | Nutrients | 2022 | 35565892 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7364/papers?page=21